PROPARACAINE HYDROCHLORIDE

PROPARACAINE HYDROCHLORIDE was reported 534 times

PROPARACAINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GASTRIC RESIDUAL INCREASED 16 0.5517
1 AQUEOUS MISDIRECTION 1 0.3333
2 PERSISTENT CORNEAL EPITHELIAL DEFECT 24 0.2034
3 ANGIOGRAM RETINA ABNORMAL 6 0.2000
4 CILIARY HYPERAEMIA 16 0.1684
5 INJURY OF CONJUNCTIVA 1 0.1429
6 CORNEAL LEUKOMA 7 0.1167
7 CORNEAL INFILTRATES 25 0.0796
8 IIIRD NERVE INJURY 1 0.0769
9 ATRIO-OESOPHAGEAL FISTULA 1 0.0769
10 CORNEAL EPITHELIUM DEFECT 42 0.0723
11 ORBITAL HAEMORRHAGE 2 0.0645
12 HYPOPYON 53 0.0640
13 TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 11 0.0608
14 CORNEAL EPITHELIUM DISORDER 2 0.0571
15 METASTATIC OCULAR MELANOMA 1 0.0400
16 ANTERIOR CHAMBER FIBRIN 5 0.0388
17 AMNIOTIC MEMBRANE GRAFT 1 0.0385
18 FEEDING INTOLERANCE 16 0.0355
19 CORNEAL THINNING 9 0.0350
20 CONJUNCTIVAL GRANULOMA 1 0.0345
21 BACTERIAL ENDOPHTHALMITIS 9 0.0338
22 RETINAL TELANGIECTASIA 1 0.0333
23 ALLERGIC KERATITIS 1 0.0333
24 ULTRASOUND BREAST ABNORMAL 1 0.0333
25 MACULAR DYSTROPHY CONGENITAL 1 0.0323
26 THYROID STIMULATING IMMUNOGLOBULIN 1 0.0323
27 INFECTIOUS CRYSTALLINE KERATOPATHY 1 0.0270
28 ACANTHAMOEBA KERATITIS 1 0.0270
29 CORNEAL OEDEMA 56 0.0250
30 CATARACT TRAUMATIC 1 0.0233
31 ALBUMIN URINE 1 0.0227
32 APHAKIA 1 0.0213
33 MULTIPLE DRUG HYPERSENSITIVITY 2 0.0208
34 CONJUNCTIVAL ABRASION 1 0.0204
35 CORNEAL NEOVASCULARISATION 5 0.0202
36 KERATOPATHY 32 0.0202
37 TOXIC ANTERIOR SEGMENT SYNDROME 22 0.0202
38 DETACHMENT OF MACULAR RETINAL PIGMENT EPITHELIUM 1 0.0192
39 POLYGLANDULAR AUTOIMMUNE SYNDROME TYPE II 1 0.0185
40 ANTERIOR CHAMBER INFLAMMATION 11 0.0185
41 CONJUNCTIVAL HYPERAEMIA 65 0.0182
42 RETINOPATHY OF PREMATURITY 10 0.0181
43 HORMONE REPLACEMENT THERAPY 1 0.0172
44 CORNEAL ULCER 1 0.0172
45 ANTERIOR CHAMBER CELL 12 0.0168
46 ARCUS LIPOIDES 1 0.0159
47 SPINAL X-RAY ABNORMAL 1 0.0141
48 ELECTROCARDIOGRAM AMBULATORY ABNORMAL 1 0.0141
49 RECURRING SKIN BOILS 1 0.0141
50 CORNEAL OPACITY 19 0.0139
51 RETINAL FIBROSIS 1 0.0139
52 HAEMORRHAGIC OCCLUSIVE RETINAL VASCULITIS 1 0.0137
53 FACTITIOUS DISORDER 2 0.0132
54 ULCERATIVE KERATITIS 36 0.0131
55 EYE INFECTION INTRAOCULAR 1 0.0128
56 PHLEBOSCLEROSIS 1 0.0128
57 MIXED DEAFNESS 1 0.0127
58 RETINAL CYST 2 0.0120
59 PUNCTATE KERATITIS 11 0.0120
60 CORNEAL SCAR 6 0.0119
61 RETINAL NEOVASCULARISATION 3 0.0119
62 OCULAR ISCHAEMIC SYNDROME 1 0.0118
63 RETINAL PIGMENT EPITHELIAL TEAR 8 0.0115
64 FLAT ANTERIOR CHAMBER OF EYE 2 0.0112
65 CORNEAL EROSION 6 0.0111
66 X-RAY LIMB ABNORMAL 1 0.0110
67 FLOPPY IRIS SYNDROME 4 0.0108
68 CORNEAL BLEEDING 1 0.0104
69 REFRACTION DISORDER 3 0.0103
70 MACULAR SCAR 2 0.0103
71 DEAFNESS PERMANENT 2 0.0102
72 NARROW ANTERIOR CHAMBER ANGLE 1 0.0102
73 PSEUDOENDOPHTHALMITIS 1 0.0101
74 OTOSCLEROSIS 1 0.0100
75 RETINAL ANEURYSM 2 0.0100
76 CORNEAL EXFOLIATION 1 0.0098
77 CHORIORETINAL ATROPHY 2 0.0097
78 CORNEAL ABSCESS 1 0.0093
79 CORNEAL TOXICITY 1 0.0090
80 EYE NAEVUS 1 0.0088
81 NORMAL TENSION GLAUCOMA 1 0.0086
82 PULMONARY VEIN STENOSIS 1 0.0085
83 PRODUCT CONTAMINATION MICROBIAL 10 0.0084
84 VITREOUS DISORDER 4 0.0083
85 VITRITIS 15 0.0081
86 CAR T-CELL-RELATED ENCEPHALOPATHY SYNDROME 1 0.0081
87 ATROPHY OF GLOBE 1 0.0078
88 CONJUNCTIVAL OEDEMA 8 0.0078
89 IRIDOCELE 1 0.0077
90 CUTIS LAXA 2 0.0074
91 EPIRETINAL MEMBRANE 2 0.0072
92 ADMINISTRATION SITE IRRITATION 1 0.0071
93 LENTICULAR OPACITIES 3 0.0069
94 HAIR GROWTH RATE ABNORMAL 1 0.0068
95 VITREOUS HAZE 1 0.0065
96 VISUAL ACUITY REDUCED TRANSIENTLY 2 0.0065
97 CORNEAL PERFORATION 4 0.0063
98 VITREOUS DEGENERATION 1 0.0061
99 PHLEBOLITH 1 0.0059
100 NON-INFECTIOUS ENDOPHTHALMITIS 5 0.0059
101 POSTERIOR CAPSULE OPACIFICATION 2 0.0058
102 TRI-IODOTHYRONINE FREE INCREASED 1 0.0058
103 ULTRASOUND DOPPLER ABNORMAL 1 0.0058
104 OPHTHALMOLOGICAL EXAMINATION ABNORMAL 1 0.0056
105 POST PROCEDURAL PAIN 1 0.0054
106 EYE INFECTION BACTERIAL 3 0.0054
107 COMPUTERISED TOMOGRAM ABDOMEN ABNORMAL 1 0.0052
108 MEDICAL DIET 1 0.0051
109 VITREAL CELLS 1 0.0050
110 OCULAR ROSACEA 1 0.0049
111 EYE EXCISION 1 0.0049
112 KERATITIS FUNGAL 1 0.0048
113 RETINAL OEDEMA 9 0.0047
114 ENDOPHTHALMITIS 28 0.0047
115 CHOROIDAL NEOVASCULARISATION 4 0.0047
116 MACULAR FIBROSIS 3 0.0044
117 ANTERIOR CHAMBER DISORDER 1 0.0043
118 RETINAL SCAR 2 0.0043
119 LACRIMATION DECREASED 2 0.0042
120 CORNEAL DEPOSITS 3 0.0040
121 VITREOUS HAEMORRHAGE 11 0.0040
122 B-CELL APLASIA 1 0.0039
123 EYE COMPLICATION ASSOCIATED WITH DEVICE 1 0.0037
124 VITREOUS DETACHMENT 8 0.0037
125 ATRIAL ENLARGEMENT 1 0.0037
126 CARDIAC SEPTAL HYPERTROPHY 1 0.0036
127 OCULAR HYPERTENSION 7 0.0036
128 CHEMICAL BURNS OF EYE 1 0.0036
129 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 5 0.0036
130 EYELID THICKENING 1 0.0035
131 RETINAL DISORDER 9 0.0035
132 LACRIMAL DISORDER 2 0.0034
133 CATARACT SUBCAPSULAR 2 0.0033
134 RETINAL ISCHAEMIA 2 0.0033
135 CORNEAL LESION 1 0.0032
136 POST PROCEDURAL INFLAMMATION 2 0.0032
137 RETINAL EXUDATES 3 0.0032
138 IODINE ALLERGY 1 0.0030
139 CONJUNCTIVITIS BACTERIAL 1 0.0029
140 METASTATIC GASTRIC CANCER 1 0.0029
141 PTERYGIUM 1 0.0029
142 EYE SYMPTOM 1 0.0028
143 BIPOLAR II DISORDER 1 0.0028
144 INFECTED DERMAL CYST 1 0.0028
145 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 1 0.0028
146 APNOEA 21 0.0027
147 ANISOCORIA 1 0.0026
148 KERATITIS 8 0.0026
149 PHYSICAL EXAMINATION ABNORMAL 1 0.0026
150 TRI-IODOTHYRONINE INCREASED 1 0.0025
151 REACTION TO PRESERVATIVES 2 0.0025
152 SEROUS RETINAL DETACHMENT 2 0.0024
153 RETINAL ARTERY OCCLUSION 6 0.0024
154 BONE SCAN ABNORMAL 1 0.0024
155 BLOOD CHLORIDE DECREASED 6 0.0023
156 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 2 0.0022
157 CORNEAL ABRASION 3 0.0022
158 KERATIC PRECIPITATES 1 0.0021
159 EYE INFLAMMATION 20 0.0021
160 FOREIGN BODY IN EYE 2 0.0021
161 PRODUCT DOSAGE FORM ISSUE 1 0.0021
162 INTRAOCULAR LENS IMPLANT 1 0.0020
163 RETROGRADE AMNESIA 1 0.0020
164 DIABETIC RETINAL OEDEMA 1 0.0020
165 GLARE 1 0.0019
166 IRIS ADHESIONS 1 0.0019
167 RETINAL HAEMORRHAGE 13 0.0018
168 PHOTOPHOBIA 34 0.0018
169 TENOSYNOVITIS STENOSANS 1 0.0018
170 BRAIN SCAN ABNORMAL 1 0.0018
171 AORTIC CALCIFICATION 1 0.0017
172 XEROPHTHALMIA 1 0.0017
173 EYE LASER SURGERY 1 0.0017
174 OPEN ANGLE GLAUCOMA 1 0.0016
175 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 2 0.0016
176 MACULAR OEDEMA 9 0.0016
177 THYROXINE FREE INCREASED 1 0.0016
178 CATARACT NUCLEAR 1 0.0015
179 ERYTHEMA OF EYELID 8 0.0015
180 DIABETIC RETINOPATHY 5 0.0015
181 CYTOKINE STORM 1 0.0015
182 RHINALGIA 4 0.0015
183 OPHTHALMIC MIGRAINE 1 0.0014
184 CRANIAL NERVE DISORDER 1 0.0014
185 GLASSY EYES 1 0.0014
186 CHORIORETINOPATHY 2 0.0014
187 ATROPHIC VULVOVAGINITIS 1 0.0014
188 CORNEAL DISORDER 3 0.0014
189 LEGAL PROBLEM 1 0.0014
190 HEART SOUNDS ABNORMAL 1 0.0013
191 ASTIGMATISM 2 0.0013
192 CHROMATOPSIA 1 0.0013
193 EYE ALLERGY 2 0.0013
194 MYOPERICARDITIS 1 0.0013
195 CORNEAL TRANSPLANT 1 0.0013
196 BLEPHAROSPASM 8 0.0013
197 RETINAL PIGMENTATION 1 0.0013
198 EYELID FUNCTION DISORDER 1 0.0013
199 INFANTILE APNOEA 1 0.0012
200 OCULAR VASCULAR DISORDER 1 0.0012
201 NEONATAL HYPOXIA 1 0.0012
202 EYELID OEDEMA 14 0.0012
203 DENTAL DISCOMFORT 1 0.0012
204 AMAUROSIS 1 0.0012
205 INTENTIONAL DEVICE USE ISSUE 1 0.0012
206 ENDOCRINE OPHTHALMOPATHY 1 0.0012
207 CEREBELLAR ATROPHY 1 0.0011
208 EYE PAIN 63 0.0011
209 ANAESTHETIC COMPLICATION NEUROLOGICAL 1 0.0011
210 METAMORPHOPSIA 2 0.0011
211 BLADDER CATHETERISATION 1 0.0010
212 VISUAL ACUITY REDUCED 34 0.0010
213 INTRAOCULAR PRESSURE INCREASED 13 0.0010
214 POSTICTAL STATE 1 0.0010
215 FOREIGN BODY SENSATION IN EYES 6 0.0009
216 LACRIMATION INCREASED 28 0.0009
217 PERIODONTITIS 2 0.0009
218 SUPERFICIAL INJURY OF EYE 1 0.0009
219 DRY AGE-RELATED MACULAR DEGENERATION 1 0.0009
220 OPEN WOUND 1 0.0009
221 CARBON DIOXIDE DECREASED 1 0.0009
222 PAROTITIS 1 0.0009
223 RETINAL VASCULITIS 1 0.0008
224 TRANSPLANT FAILURE 2 0.0008
225 EYE OEDEMA 2 0.0008
226 VITREOUS FLOATERS 8 0.0008
227 STAPHYLOCOCCAL SKIN INFECTION 1 0.0008
228 BRADYCARDIA NEONATAL 1 0.0008
229 CONJUNCTIVAL HAEMORRHAGE 3 0.0008
230 LEFT ATRIAL DILATATION 1 0.0008
231 NOCTURNAL DYSPNOEA 1 0.0008
232 MYDRIASIS 10 0.0008
233 RETINAL DEGENERATION 1 0.0008
234 TONIC CLONIC MOVEMENTS 1 0.0008
235 SINUS ARRHYTHMIA 1 0.0008
236 BLEPHARITIS 3 0.0007
237 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
238 ECHOCARDIOGRAM ABNORMAL 1 0.0007
239 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0007
240 DRUG ABUSE 59 0.0007
241 RETINAL VEIN OCCLUSION 2 0.0007
242 CONJUNCTIVITIS ALLERGIC 1 0.0007
243 AXILLARY PAIN 1 0.0007
244 IRITIS 2 0.0007
245 THERAPEUTIC PRODUCT EFFECT DELAYED 3 0.0007
246 BLOOD PRESSURE IMMEASURABLE 1 0.0007
247 RETINAL DETACHMENT 6 0.0007
248 CHEST X-RAY ABNORMAL 2 0.0007
249 DAYDREAMING 1 0.0006
250 EYELIDS PRURITUS 2 0.0006
251 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
252 IRIDOCYCLITIS 2 0.0006
253 PHOTOPSIA 4 0.0006
254 INTERMITTENT CLAUDICATION 1 0.0006
255 COSTOCHONDRITIS 1 0.0006
256 OPTIC ATROPHY 1 0.0006
257 DEAFNESS NEUROSENSORY 2 0.0006
258 ILLUSION 1 0.0006
259 RESUSCITATION 1 0.0006
260 TROPONIN I INCREASED 1 0.0006
261 LOWER RESPIRATORY TRACT CONGESTION 1 0.0006
262 CAROTID ARTERY STENOSIS 2 0.0006
263 BREAST CYST 1 0.0006
264 AORTIC VALVE STENOSIS 1 0.0006
265 BLINDNESS TRANSIENT 4 0.0005
266 PUPILLARY REFLEX IMPAIRED 1 0.0005
267 STENOSIS 1 0.0005
268 CYSTOID MACULAR OEDEMA 1 0.0005
269 SACROILIITIS 1 0.0005
270 INFECTED SKIN ULCER 1 0.0005
271 POST PROCEDURAL COMPLICATION 10 0.0005
272 HYPERAEMIA 1 0.0005
273 CARDIAC DISCOMFORT 1 0.0005
274 ANAPHYLACTOID REACTION 2 0.0005
275 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
276 HYPERPHOSPHATAEMIA 1 0.0005
277 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
278 DIABETIC NEPHROPATHY 1 0.0005
279 PHYSICAL DISABILITY 2 0.0005
280 CHRONIC GASTRITIS 1 0.0004
281 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
282 BLINDNESS UNILATERAL 6 0.0004
283 DIABETES INSIPIDUS 1 0.0004
284 SLOW SPEECH 1 0.0004
285 INSTILLATION SITE PAIN 1 0.0004
286 TACHYARRHYTHMIA 1 0.0004
287 VENTRICULAR HYPERTROPHY 1 0.0004
288 ANGLE CLOSURE GLAUCOMA 1 0.0004
289 AORTIC ARTERIOSCLEROSIS 1 0.0004
290 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
291 ANIMAL BITE 1 0.0004
292 ANAESTHETIC COMPLICATION 1 0.0004
293 BLOOD SODIUM DECREASED 7 0.0004
294 UVEITIS 5 0.0004
295 ASTHENOPIA 2 0.0004
296 GLAUCOMA 7 0.0004
297 CARDIAC VALVE DISEASE 2 0.0003
298 LUNG CANCER METASTATIC 1 0.0003
299 PULMONARY PAIN 1 0.0003
300 STRIDOR 1 0.0003
301 ACUTE MYOCARDIAL INFARCTION 10 0.0003
302 WRONG DRUG ADMINISTERED 3 0.0003
303 CREPITATIONS 1 0.0003
304 VISION BLURRED 46 0.0003
305 CEREBROVASCULAR DISORDER 1 0.0003
306 LOSS OF EMPLOYMENT 1 0.0003
307 CRANIOCEREBRAL INJURY 1 0.0003
308 EYE INJURY 1 0.0003
309 SELF INJURIOUS BEHAVIOUR 1 0.0003
310 DIABETIC FOOT 1 0.0003
311 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
312 ORTHOPNOEA 1 0.0003
313 ANAPHYLACTIC SHOCK 8 0.0003
314 CATARACT 18 0.0003
315 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0003
316 OCULAR HYPERAEMIA 14 0.0003
317 PRODUCT LABEL ISSUE 2 0.0003
318 HYPOPNOEA 1 0.0003
319 TYPE I HYPERSENSITIVITY 1 0.0003
320 MACULOPATHY 1 0.0003
321 EYE IRRITATION 16 0.0003
322 FACIAL BONES FRACTURE 1 0.0003
323 CONJUNCTIVITIS 5 0.0003
324 HYPONATRAEMIA 15 0.0003
325 ECONOMIC PROBLEM 4 0.0003
326 CERVIX CARCINOMA 1 0.0003
327 POLYDIPSIA 1 0.0003
328 NASAL DISCOMFORT 2 0.0003
329 MACULAR DEGENERATION 3 0.0003
330 CEREBRAL ATROPHY 1 0.0003
331 INTENTIONAL PRODUCT USE ISSUE 21 0.0002
332 BUNDLE BRANCH BLOCK LEFT 1 0.0002
333 PURULENT DISCHARGE 1 0.0002
334 ABNORMAL SENSATION IN EYE 1 0.0002
335 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
336 COLD SWEAT 4 0.0002
337 CATHETERISATION CARDIAC 1 0.0002
338 EYE HAEMORRHAGE 3 0.0002
339 RHINITIS ALLERGIC 1 0.0002
340 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
341 EXOSTOSIS 2 0.0002
342 ROSACEA 1 0.0002
343 ARTERIOSCLEROSIS 2 0.0002
344 PULSE ABSENT 1 0.0002
345 DISEASE RECURRENCE 10 0.0002
346 HORMONE LEVEL ABNORMAL 1 0.0002
347 RENAL CELL CARCINOMA 1 0.0002
348 PHARYNGEAL SWELLING 2 0.0002
349 BREATH SOUNDS ABNORMAL 1 0.0002
350 EXPIRED DRUG ADMINISTERED 1 0.0002
351 FOOT OPERATION 1 0.0002
352 DIABETIC NEUROPATHY 1 0.0002
353 ANEURYSM 1 0.0002
354 DRY EYE 10 0.0002
355 INCREASED UPPER AIRWAY SECRETION 1 0.0002
356 UNRESPONSIVE TO STIMULI 5 0.0002
357 VARICOSE VEIN 1 0.0002
358 EYE DISCHARGE 2 0.0002
359 BLOOD LACTIC ACID INCREASED 1 0.0002
360 NORMAL NEWBORN 1 0.0002
361 NECROSIS 1 0.0002
362 ANGIOPATHY 1 0.0002
363 DERMATITIS CONTACT 2 0.0002
364 VISUAL DISTURBANCE 1 0.0002
365 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
366 HYPERLIPIDAEMIA 2 0.0002
367 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
368 ABDOMINAL DISTENSION 17 0.0002
369 DRUG ABUSER 1 0.0002
370 VISUAL IMPAIRMENT 20 0.0002
371 SWELLING OF EYELID 1 0.0002
372 ANGINA UNSTABLE 1 0.0002
373 ASPERGILLUS INFECTION 1 0.0002
374 EYE DISORDER 5 0.0002
375 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
376 BREAST MASS 1 0.0001
377 BLINDNESS 6 0.0001
378 ECCHYMOSIS 1 0.0001
379 PERIPHERAL COLDNESS 2 0.0001
380 ONYCHOCLASIS 1 0.0001
381 JOINT EFFUSION 1 0.0001
382 HYPERTRANSAMINASAEMIA 1 0.0001
383 DEFAECATION URGENCY 1 0.0001
384 APPLICATION SITE REACTION 1 0.0001
385 RETCHING 3 0.0001
386 PRODUCT SUPPLY ISSUE 1 0.0001
387 IMPAIRED QUALITY OF LIFE 2 0.0001
388 VISUAL FIELD DEFECT 1 0.0001
389 INTENTIONAL PRODUCT MISUSE 12 0.0001
390 MAJOR DEPRESSION 1 0.0001
391 EYE SWELLING 5 0.0001
392 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
393 BREAST TENDERNESS 1 0.0001
394 OSTEOPENIA 2 0.0001
395 HAEMODYNAMIC INSTABILITY 1 0.0001
396 BOWEL MOVEMENT IRREGULARITY 1 0.0001
397 PROCEDURAL COMPLICATION 1 0.0001
398 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
399 APHTHOUS ULCER 1 0.0001
400 PULMONARY HAEMORRHAGE 1 0.0001
401 CYANOSIS 2 0.0001
402 FURUNCLE 1 0.0001
403 TRANSPLANT REJECTION 1 0.0001
404 SENSORY LOSS 1 0.0001
405 POLYURIA 1 0.0001
406 IMPAIRED HEALING 4 0.0001
407 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
408 VENTRICULAR TACHYCARDIA 2 0.0001
409 URINARY RETENTION 4 0.0001
410 SENSATION OF FOREIGN BODY 1 0.0001
411 SCAR 2 0.0001
412 CARDIAC MURMUR 1 0.0001
413 ORTHOSTATIC HYPOTENSION 2 0.0001
414 NAIL DISORDER 1 0.0001
415 ANHEDONIA 3 0.0001
416 SPINAL OSTEOARTHRITIS 1 0.0001
417 TUMOUR LYSIS SYNDROME 1 0.0001
418 FACIAL PAIN 1 0.0001
419 OROPHARYNGEAL DISCOMFORT 1 0.0001
420 DEFORMITY 1 0.0001
421 DIARRHOEA HAEMORRHAGIC 1 0.0001
422 LACERATION 1 0.0001
423 BLOOD PRESSURE DECREASED 7 0.0001
424 ATELECTASIS 1 0.0001
425 DIZZINESS POSTURAL 1 0.0001
426 AUTOIMMUNE DISORDER 1 0.0001
427 OFF LABEL USE 89 0.0001
428 DISABILITY 2 0.0001
429 LIGAMENT SPRAIN 1 0.0001
430 SYNCOPE 10 0.0001
431 EYELID PTOSIS 1 0.0001
432 EAR DISCOMFORT 1 0.0001
433 TEMPERATURE INTOLERANCE 1 0.0001
434 SKELETAL INJURY 1 0.0001
435 DERMATITIS 2 0.0001
436 INJECTION SITE DISCOMFORT 1 0.0001
437 HEAD INJURY 3 0.0001
438 BLOOD GLUCOSE FLUCTUATION 1 0.0001
439 TOOTH FRACTURE 1 0.0001
440 EYE PRURITUS 3 0.0001
441 SKIN INFECTION 1 0.0001
442 STATUS EPILEPTICUS 1 0.0001
443 HEART RATE IRREGULAR 2 0.0001
444 TINNITUS 4 0.0001
445 HEART RATE DECREASED 3 0.0001
446 NOCTURIA 1 0.0001
447 PRESYNCOPE 2 0.0001
448 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
449 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
450 CHEST DISCOMFORT 8 0.0001
451 LOSS OF CONSCIOUSNESS 10 0.0001
452 NODULE 1 0.0001
453 DEAFNESS 2 0.0001
454 SARS-COV-2 TEST POSITIVE 1 0.0001
455 ADVERSE REACTION 1 0.0001
456 JOINT RANGE OF MOTION DECREASED 1 0.0001
457 TACHYPNOEA 1 0.0001
458 PALLOR 2 0.0001
459 IMPAIRED GASTRIC EMPTYING 1 0.0001
460 CORONARY ARTERY OCCLUSION 1 0.0001
461 PARALYSIS 1 0.0001
462 ANGINA PECTORIS 2 0.0001
463 HYPERTHYROIDISM 1 0.0001
464 NASAL CONGESTION 4 0.0001
465 PRODUCT QUALITY ISSUE 9 0.0001
466 DRUG DISPENSING ERROR 1 0.0001
467 THYROID DISORDER 1 0.0001
468 MUSCULOSKELETAL CHEST PAIN 1 0.0001
469 PRODUCT USE IN UNAPPROVED INDICATION 16 0.0001
470 BASAL CELL CARCINOMA 1 0.0001
471 PRODUCT USE COMPLAINT 1 0.0001
472 HYPOTHYROIDISM 2 0.0001
473 BLOOD POTASSIUM INCREASED 1 0.0001
474 STAPHYLOCOCCAL INFECTION 2 0.0001
475 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
476 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
477 PALPITATIONS 7 0.0001
478 BLOOD UREA INCREASED 1 0.0001
479 CANDIDA INFECTION 1 0.0001
480 HAEMATURIA 2 0.0001
481 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
482 INFLAMMATION 3 0.0001
483 LOCAL SWELLING 1 0.0001
484 PRODUCT STORAGE ERROR 5 0.0001
485 NEUROTOXICITY 1 0.0001
486 INJURY 4 0.0001
487 METASTASES TO LIVER 1 0.0001
488 BRADYCARDIA 3 0.0001
489 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
490 THIRST 1 0.0001
491 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
492 TREATMENT NONCOMPLIANCE 3 0.0001
493 END STAGE RENAL DISEASE 1 0.0001
494 HYPERSENSITIVITY 10 0.0001
495 HEPATIC STEATOSIS 1 0.0001
496 OXYGEN SATURATION DECREASED 3 0.0001
497 DYSPNOEA EXERTIONAL 2 0.0001
498 HYPOCALCAEMIA 1 0.0001
499 PROTEINURIA 1 0.0001
500 PULMONARY FIBROSIS 1 0.0001
501 PRESCRIBED OVERDOSE 1 0.0001
502 EAR PAIN 1 0.0001
503 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
504 HAEMATOCRIT DECREASED 1 0.0001
505 CYTOKINE RELEASE SYNDROME 1 0.0000
506 EXTRA DOSE ADMINISTERED 2 0.0000
507 BONE MARROW FAILURE 1 0.0000
508 DISCOMFORT 3 0.0000
509 INJURY ASSOCIATED WITH DEVICE 1 0.0000
510 BODY TEMPERATURE INCREASED 1 0.0000
511 LUNG NEOPLASM MALIGNANT 2 0.0000
512 PULMONARY HYPERTENSION 1 0.0000
513 KNEE ARTHROPLASTY 1 0.0000
514 CEREBROVASCULAR ACCIDENT 8 0.0000
515 HYPERTENSION 10 0.0000
516 OSTEOARTHRITIS 2 0.0000
517 JOINT INJURY 1 0.0000
518 LIVER FUNCTION TEST INCREASED 1 0.0000
519 HYPERHIDROSIS 6 0.0000
520 HYPOACUSIS 2 0.0000
521 MELAENA 1 0.0000
522 APPLICATION SITE PAIN 1 0.0000
523 THROAT IRRITATION 2 0.0000
524 SHOCK 1 0.0000
525 PERICARDIAL EFFUSION 1 0.0000
526 VOMITING 20 0.0000
527 ARRHYTHMIA 2 0.0000
528 TOXICITY TO VARIOUS AGENTS 7 0.0000
529 NEURALGIA 1 0.0000
530 ATRIAL FIBRILLATION 4 0.0000
531 AGEUSIA 1 0.0000
532 HYPOAESTHESIA 6 0.0000
533 SPEECH DISORDER 2 0.0000
534 JOINT STIFFNESS 1 0.0000
535 FREQUENT BOWEL MOVEMENTS 1 0.0000
536 THROAT TIGHTNESS 1 0.0000
537 LIMB INJURY 1 0.0000
538 MOOD ALTERED 1 0.0000
539 SKIN LESION 1 0.0000
540 CARDIAC ARREST 3 0.0000
541 TREMOR 6 0.0000
542 DIVERTICULITIS 1 0.0000
543 WOUND 1 0.0000
544 HERPES ZOSTER 2 0.0000
545 BLOOD POTASSIUM DECREASED 1 0.0000
546 EMOTIONAL DISTRESS 4 0.0000
547 CORONARY ARTERY DISEASE 1 0.0000
548 ILL-DEFINED DISORDER 2 0.0000
549 EPILEPSY 1 0.0000
550 CHEST PAIN 6 0.0000
551 PRODUCT USE ISSUE 6 0.0000
552 CONTUSION 3 0.0000
553 LACTIC ACIDOSIS 1 0.0000
554 SWELLING FACE 2 0.0000
555 OSTEONECROSIS 1 0.0000
556 EXPIRED PRODUCT ADMINISTERED 1 0.0000
557 DELIRIUM 1 0.0000
558 DEVICE USE ERROR 1 0.0000
559 HYPERKALAEMIA 1 0.0000
560 HYPOXIA 1 0.0000
561 HYPERGLYCAEMIA 1 0.0000
562 RESPIRATORY FAILURE 2 0.0000
563 SEPSIS 3 0.0000
564 DYSARTHRIA 1 0.0000
565 HALLUCINATION 2 0.0000
566 DIABETES MELLITUS 2 0.0000
567 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
568 CHILLS 3 0.0000
569 ABNORMAL BEHAVIOUR 1 0.0000
570 ANXIETY 7 0.0000
571 DIZZINESS 12 0.0000
572 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
573 CARDIO-RESPIRATORY ARREST 1 0.0000
574 MYALGIA 4 0.0000
575 RECTAL HAEMORRHAGE 1 0.0000
576 DEVICE DISLOCATION 1 0.0000
577 SEPTIC SHOCK 1 0.0000
578 RENAL FAILURE 3 0.0000
579 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
580 OROPHARYNGEAL PAIN 2 0.0000
581 BACK PAIN 5 0.0000
582 RENAL DISORDER 1 0.0000
583 BLOOD CHOLESTEROL INCREASED 1 0.0000
584 CARDIAC DISORDER 2 0.0000
585 SWELLING 2 0.0000
586 DYSPHAGIA 2 0.0000
587 NEUROPATHY PERIPHERAL 2 0.0000
588 MIGRAINE 2 0.0000
589 PRODUCTIVE COUGH 1 0.0000
590 RASH ERYTHEMATOUS 1 0.0000
591 BLOOD GLUCOSE DECREASED 1 0.0000
592 HYPOGLYCAEMIA 1 0.0000
593 AGGRESSION 1 0.0000
594 HYPOTENSION 4 0.0000
595 CELLULITIS 1 0.0000
596 THERAPY CESSATION 1 0.0000
597 HAEMOGLOBIN DECREASED 2 0.0000
598 ILLNESS 2 0.0000
599 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
600 NERVOUSNESS 1 0.0000
601 ECZEMA 1 0.0000
602 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
603 INSOMNIA 5 0.0000
604 RASH PRURITIC 1 0.0000
605 OEDEMA 1 0.0000
606 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
607 FALL 6 0.0000
608 NECK PAIN 1 0.0000
609 DYSPNOEA 10 0.0000
610 MUSCULAR WEAKNESS 2 0.0000
611 HEADACHE 11 0.0000
612 CONVULSION 1 0.0000
613 PRODUCT SUBSTITUTION ISSUE 1 0.0000
614 SEIZURE 2 0.0000
615 WHEEZING 1 0.0000
616 THERAPEUTIC RESPONSE DECREASED 1 0.0000
617 CONDITION AGGRAVATED 5 0.0000
618 NAUSEA 13 0.0000
619 MUSCLE SPASMS 3 0.0000
620 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
621 BLOOD GLUCOSE INCREASED 3 0.0000
622 RHINORRHOEA 1 0.0000
623 BLOOD CREATININE INCREASED 1 0.0000
624 PAIN 9 0.0000
625 ABDOMINAL PAIN UPPER 3 0.0000
626 PYREXIA 5 0.0000
627 COUGH 4 0.0000
628 BURNING SENSATION 1 0.0000
629 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
630 AGITATION 1 0.0000
631 BRONCHITIS 1 0.0000
632 EPISTAXIS 1 0.0000
633 HOT FLUSH 1 0.0000
634 DEPRESSION 3 0.0000
635 CHRONIC KIDNEY DISEASE 1 0.0000
636 ACUTE KIDNEY INJURY 2 0.0000
637 DECREASED APPETITE 3 0.0000
638 ARTHRITIS 1 0.0000
639 PARAESTHESIA 2 0.0000
640 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
641 CONFUSIONAL STATE 2 0.0000
642 PNEUMONIA 4 0.0000
643 DRY MOUTH 1 0.0000
644 INFLUENZA LIKE ILLNESS 1 0.0000
645 BALANCE DISORDER 1 0.0000
646 FATIGUE 9 0.0000
647 MYOCARDIAL INFARCTION 2 0.0000
648 MUSCULOSKELETAL STIFFNESS 1 0.0000
649 TACHYCARDIA 1 0.0000
650 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
651 WEIGHT DECREASED 3 0.0000
652 ASTHENIA 4 0.0000
653 GAIT DISTURBANCE 2 0.0000
654 PRURITUS 4 0.0000
655 ALOPECIA 2 0.0000
656 HEART RATE INCREASED 1 0.0000
657 FLUSHING 1 0.0000
658 HAEMORRHAGE 1 0.0000
659 OVERDOSE 2 0.0000
660 CONSTIPATION 2 0.0000
661 INFLUENZA 1 0.0000
662 ASTHMA 1 0.0000
663 INCORRECT DOSE ADMINISTERED 2 0.0000
664 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
665 DISEASE PROGRESSION 1 0.0000
666 JOINT SWELLING 1 0.0000
667 DRY SKIN 1 0.0000
668 NEUTROPENIA 1 0.0000
669 DEATH 6 0.0000
670 BLOOD PRESSURE INCREASED 1 0.0000
671 PERIPHERAL SWELLING 1 0.0000
672 DRUG INTERACTION 1 0.0000
673 DRUG DEPENDENCE 1 0.0000
674 DIARRHOEA 4 0.0000
675 DRUG INEFFECTIVE 8 0.0000
676 DRUG DOSE OMISSION 1 0.0000
677 ABDOMINAL DISCOMFORT 1 0.0000
678 COVID-19 1 0.0000
679 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
680 NO ADVERSE EVENT 1 0.0000
681 ANAEMIA 1 0.0000
682 SOMNOLENCE 1 0.0000
683 ARTHRALGIA 2 0.0000
684 RASH 2 0.0000
685 MALAISE 2 0.0000
686 WEIGHT INCREASED 1 0.0000
687 FEELING ABNORMAL 1 0.0000
688 INJECTION SITE PAIN 1 0.0000